Genetics
Breast cancer and heart disease may have common roots
Women who are at risk for breast cancer may also be at greater risk for heart disease, new research has found.
Dec 20, 2011
0
0
News tagged with doxorubicin
Oncology & Cancer
Study suggests drug intervention may prevent doxorubicin-induced cardiac injury
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
Jan 25, 2021
0
39
Cardiology
Doxorubicin disrupts the immune system to cause heart toxicity
Doxorubicin is a chemotherapy drug widely used in ovarian, bladder, lung, thyroid and stomach cancers, but it carries a harmful side effect. The drug causes a dose-dependent heart toxicity that can lead to congestive heart ...
Aug 6, 2018
0
13
Cardiology
Study findings show promise in preventing heart disease in cancer survivors
A new study by Washington State University researchers suggests that a protein called CDK2 plays a critical role in heart damage caused by doxorubicin, a commonly used chemotherapy drug.
Nov 7, 2018
0
18
Oncology & Cancer
Taxane + platinum feasible for adjuvant tx in endometrial cancer
(HealthDay)—Taxane plus platinum regimens may be a reasonable alternative to doxorubicin plus cisplatin as postoperative adjuvant chemotherapy for endometrial cancer that carries a high risk for progression, according to ...
Mar 27, 2019
0
1
Oncology & Cancer
Research identifies critical protein in cancer treatment-related heart damage
Many cancers can be successfully treated, but treatment itself often comes with risks as well. Cancer therapy that uses anthracyclines—a class of commonly used chemotherapy drugs—has been associated with heart damage ...
Apr 9, 2020
0
7
Cardiology
Dietary inorganic nitrate may reduce heart dysfunction caused by powerful anti-cancer drug
Virginia Commonwealth University researchers have found that nutrient supplementation, like the kind that is found in leafy greens, spinach and lettuce, may reduce the damage to the heart caused by a powerful anti-cancer ...
May 19, 2011
0
0
Medications
New drug approved for lack of certain white blood cells
(HealthDay)—The U.S. Food and Drug Administration has approved the drug tbo-filgrastim to treat certain cancer patients undergoing chemotherapy who have a condition called severe neutropenia, the FDA said in a news release.
Aug 30, 2012
0
0
Medications
Some chemotherapy side effects caused by single mutation could be prevented
Harmful side effects from a common chemotherapy drug could be the result of a single mutation, according to a study published in Cell Stem Cell.
Sep 27, 2021
0
68
Oncology & Cancer
Hepatitis B screening before chemo deemed cost-effective
(HealthDay) -- Universal hepatitis B virus (HBV) screening before chemotherapy for lymphoma reduces costs in most settings, according to a study published online June 18 in the Journal of Clinical Oncology.
Jun 20, 2012
0
0
